ArticleJournal of personalized medicine2021

Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease.

Laura A Lucaciu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.